Outlive by Peter Attia 2025 Review: Still the Best Longevity Book Ever Written? (Yes — With 3 Important Updates)
When Outlive: The Science and Art of Longevity dropped in March 2023, it instantly became the new bible of evidence-based longevity.
Peter Attia MD — a former surgeon turned longevity obsessive who trains like an elite athlete, tracks every biomarker imaginable, and treats ultra-high-net-worth clients — laid out “Medicine 3.0”: stop waiting for disease to strike and instead aggressively prevent the Four Horsemen (atherosclerotic disease, cancer, neurodegenerative disease, and metabolic dysfunction).
Two and a half years and millions of copies later, the book sales are still crushing it, the subreddit is thriving, and Attia just launched the official Outlive app.
So here’s the real question in late 2025: Does Outlive still hold up?
Short answer: It’s not just holding up — it’s aged like the finest rapamycin-treated mouse. Almost everything in the book is even more strongly supported today than in 2023. The core prescription remains the gold standard.But science moved fast in a few areas (especially drugs for obesity and new exercise data), so here’s the definitive 2025 verdict.What Attia Got Spectacularly Right (Still 100% Correct — Actually Stronger Now)
From Attia’s latest 2025 disclosures:
The only reason it’s not a perfect 10 is the GLP-1 revolution happened right after publication, but Attia has more than made up for it with hundreds of podcast hours updating everything.
If you haven’t read it yet, buy it today. If you read it in 2023, re-read chapters 12–16 (exercise) and the emotional health chapter — they hit even harder the second time.
And if Peter Attia ever writes Outlive 2 incorporating GLP-1s, next-gen rapamycin analogs, and plasma exchange data, it will instantly become the new standard again.
Until then, this 2023 book remains the North Star of longevity in 2025. Train hard, eat protein max, sleep like your life depends on it (it does), and go live your marginal decade like a boss.
Two and a half years and millions of copies later, the book sales are still crushing it, the subreddit is thriving, and Attia just launched the official Outlive app.
So here’s the real question in late 2025: Does Outlive still hold up?
Short answer: It’s not just holding up — it’s aged like the finest rapamycin-treated mouse. Almost everything in the book is even more strongly supported today than in 2023. The core prescription remains the gold standard.But science moved fast in a few areas (especially drugs for obesity and new exercise data), so here’s the definitive 2025 verdict.What Attia Got Spectacularly Right (Still 100% Correct — Actually Stronger Now)
- Exercise is the most powerful longevity drug we have. Full stop.
The data has only gotten stronger. 2024–2025 meta-analyses confirm VO2 max is the single strongest predictor of all-cause mortality — every 1 MET increase ≈ 10–20% lower risk of death. Strength training, Zone 2 cardio, and Zone 5 VO2 max work remain the unbeatable trifecta. - You must train for your “Centenarian Decathlon”
The idea of training specifically for the physical tasks you want to do at 100 (play with grandkids, carry groceries, get off the floor) is genius and now copied everywhere. It’s the single best framework for exercise prescription. - Protein is non-negotiable (1.6–2.2 g/kg ideal, higher if very active)
The 2024–2025 protein wars are over. High-protein diets won. New RCTs show superior muscle preservation, satiety, and metabolic health vs low-protein. - Sleep and emotional health are foundational
The emotional health chapter — Attia’s raw discussion of his own mental health struggles — is still the most underrated part of the book. In 2025 we have even more data linking unresolved trauma, depression, and poor sleep to accelerated biological aging (higher epigenetic age acceleration). - Medicine 3.0 mindset
Don’t wait for disease. Use advanced testing (ApoB, Lp(a), continuous glucose monitors, DEXA, oral glucose tolerance tests with insulin assay) early and often. This is now mainstream among progressive physicians. - Stability and grip strength are the new biomarkers
Attia’s emphasis on grip, balance, and eccentric strength was ahead of its time. New 2025 studies show inability to stand from seated without hands predicts mortality better than smoking.
- GLP-1 agonists (Ozempic, Mounjaro, retatrutide, etc.) have completely rewritten the metabolic chapter
The book barely mentions them because the pivotal trials finished right after publication. In 2025, tirzepatide and newer dual/triple agonists are game-changers for obesity, insulin resistance, NAFLD, and even cardiovascular risk reduction. Attia now says on his podcast that for many patients these drugs are “the most important medical breakthrough in decades.” If you’re overweight or insulin-resistant, these move to the top of the protocol. - Rapamycin is still promising but evidence remains preliminary
Attia takes 6–13 mg weekly/monthly. In 2025 we have better human data (mostly from organ transplant patients and small studies) showing immune effects are dose-dependent, and higher doses may accelerate aging in some tissues. Most experts (including Attia in recent 2025 podcasts) now favor lower, intermittent dosing or rapamycin “holidays.” Verdict: Still worth experimenting with if you’re optimized everywhere else, but not the slam-dunk Attia hoped in 2023. - Extended fasting is out; time-efficient exercise + protein is in
Attia has publicly walked back his earlier keto + long-fasting enthusiasm. He now says >3-day fasts provide diminishing returns and risk muscle loss. His current protocol: eat 1.8–2.2 g/kg protein, do resistance training, keep time-restricted eating window 10–12 hours max if it feels good.
- Sleep 7.5–9 hours/night, consistent schedule
- Emotional health work (therapy, journaling, relationships)
- No smoking, minimal alcohol (≤7 drinks/week max)
- 4× per week resistance training (full-body or push/pull/legs, to failure on last set)
- 150–180 min/week Zone 2 cardio (can talk but not sing)
- 1× high-intensity session/week (4×4-minute intervals at 95%+ effort or rucking with heavy pack)
- Daily stability/grip work (dead hangs, single-leg balance, farmer carries)
- Goal: Top 10% VO2 max and strength for your age by 50, top 25% by 80
- Protein: 1.6–2.2 g/kg bodyweight (prioritize animal sources for leucine)
- Total calories: maintain healthy body fat (men 10–18%, women 18–28%)
- If overweight/insulin resistant → consider GLP-1 agonist with physician (tirzepatide > semaglutide in 2025 head-to-head trials)
- Micronutrients via food first (berries, cruciferous veg, fermented foods, olive oil, nuts)
- Early screening: ApoB, Lp(a), OGTT + insulin, coronary calcium score at 40–50
- Consider: low-dose rapamycin (6 mg every 7–14 days), therapeutic plasma exchange, or advanced peptides if in Attia-level optimization mode
- Continuous glucose monitor annually or during experimentation
From Attia’s latest 2025 disclosures:
- Protein powder, omega-3s (2–3 g EPA/DHA), vitamin D, magnesium, glycine + Ashwagandha for sleep, baby aspirin (if high risk), AREDS2 for eyes.
The only reason it’s not a perfect 10 is the GLP-1 revolution happened right after publication, but Attia has more than made up for it with hundreds of podcast hours updating everything.
If you haven’t read it yet, buy it today. If you read it in 2023, re-read chapters 12–16 (exercise) and the emotional health chapter — they hit even harder the second time.
And if Peter Attia ever writes Outlive 2 incorporating GLP-1s, next-gen rapamycin analogs, and plasma exchange data, it will instantly become the new standard again.
Until then, this 2023 book remains the North Star of longevity in 2025. Train hard, eat protein max, sleep like your life depends on it (it does), and go live your marginal decade like a boss.
Comments